论文部分内容阅读
The interaction between mesenchymal stem cells (MSCs) and dendritic cells (DCs) affects T cell development and function.Further, the chemotactic capacity of MSCs, their interaction with the tumor microenvironment, and the intervention of immune-stimulatory molecules suggest possible exploitation of tumor necrosis factor-α (TNF-α) and CD40 ligand (CD40L) to genetically modify MSCs for enhanced cancer therapy.Both DCs and MSCs were isolated from BALB/c mice.